 | • レポートコード：QYR2104Z4856 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、精神治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、抗不安薬、気分安定薬、抗精神病薬）、用途別市場規模（病院用、診療所用、家庭用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・精神治療薬の市場動向 ・企業の競争状況、市場シェア ・精神治療薬の種類別市場規模（抗うつ薬、抗不安薬、気分安定薬、抗精神病薬） ・精神治療薬の用途別市場規模（病院用、診療所用、家庭用） ・精神治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・精神治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・精神治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・精神治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・精神治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、AstraZeneca、Eli Lilly and Company、GlaxoSmithKline、Johnson & Johnson、Novartis、H. Lundbeck、Abbott Laboratories、Otsuka Pharmaceutical、Gedeon Richter、Lupin Pharmaceuticals、Luye Pharma、SK Biopharmaceuticals） ・結論 |
Market Analysis and Insights: Global Psychiatric Medications Market
The global Psychiatric Medications market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Psychiatric Medications market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Psychiatric Medications market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Psychiatric Medications market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Psychiatric Medications market.
Global Psychiatric Medications Scope and Market Size
Psychiatric Medications market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Psychiatric Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antidepressants
Anti-anxiety Medications
Mood-stabilizing Medications
Antipsychotic Medications
Segment by Application
Hospital Use
Clinic Use
Household
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Johnson & Johnson
Novartis
H. Lundbeck
Abbott Laboratories
Otsuka Pharmaceutical
Gedeon Richter
Lupin Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psychiatric Medications Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antidepressants
1.2.3 Anti-anxiety Medications
1.2.4 Mood-stabilizing Medications
1.2.5 Antipsychotic Medications
1.3 Market by Application
1.3.1 Global Psychiatric Medications Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Psychiatric Medications Market Perspective (2016-2027)
2.2 Psychiatric Medications Growth Trends by Regions
2.2.1 Psychiatric Medications Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Psychiatric Medications Historic Market Share by Regions (2016-2021)
2.2.3 Psychiatric Medications Forecasted Market Size by Regions (2022-2027)
2.3 Psychiatric Medications Industry Dynamic
2.3.1 Psychiatric Medications Market Trends
2.3.2 Psychiatric Medications Market Drivers
2.3.3 Psychiatric Medications Market Challenges
2.3.4 Psychiatric Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psychiatric Medications Players by Revenue
3.1.1 Global Top Psychiatric Medications Players by Revenue (2016-2021)
3.1.2 Global Psychiatric Medications Revenue Market Share by Players (2016-2021)
3.2 Global Psychiatric Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Psychiatric Medications Revenue
3.4 Global Psychiatric Medications Market Concentration Ratio
3.4.1 Global Psychiatric Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psychiatric Medications Revenue in 2020
3.5 Psychiatric Medications Key Players Head office and Area Served
3.6 Key Players Psychiatric Medications Product Solution and Service
3.7 Date of Enter into Psychiatric Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psychiatric Medications Breakdown Data by Type
4.1 Global Psychiatric Medications Historic Market Size by Type (2016-2021)
4.2 Global Psychiatric Medications Forecasted Market Size by Type (2022-2027)
5 Psychiatric Medications Breakdown Data by Application
5.1 Global Psychiatric Medications Historic Market Size by Application (2016-2021)
5.2 Global Psychiatric Medications Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Psychiatric Medications Market Size (2016-2027)
6.2 North America Psychiatric Medications Market Size by Type
6.2.1 North America Psychiatric Medications Market Size by Type (2016-2021)
6.2.2 North America Psychiatric Medications Market Size by Type (2022-2027)
6.2.3 North America Psychiatric Medications Market Size by Type (2016-2027)
6.3 North America Psychiatric Medications Market Size by Application
6.3.1 North America Psychiatric Medications Market Size by Application (2016-2021)
6.3.2 North America Psychiatric Medications Market Size by Application (2022-2027)
6.3.3 North America Psychiatric Medications Market Size by Application (2016-2027)
6.4 North America Psychiatric Medications Market Size by Country
6.4.1 North America Psychiatric Medications Market Size by Country (2016-2021)
6.4.2 North America Psychiatric Medications Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Psychiatric Medications Market Size (2016-2027)
7.2 Europe Psychiatric Medications Market Size by Type
7.2.1 Europe Psychiatric Medications Market Size by Type (2016-2021)
7.2.2 Europe Psychiatric Medications Market Size by Type (2022-2027)
7.2.3 Europe Psychiatric Medications Market Size by Type (2016-2027)
7.3 Europe Psychiatric Medications Market Size by Application
7.3.1 Europe Psychiatric Medications Market Size by Application (2016-2021)
7.3.2 Europe Psychiatric Medications Market Size by Application (2022-2027)
7.3.3 Europe Psychiatric Medications Market Size by Application (2016-2027)
7.4 Europe Psychiatric Medications Market Size by Country
7.4.1 Europe Psychiatric Medications Market Size by Country (2016-2021)
7.4.2 Europe Psychiatric Medications Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Psychiatric Medications Market Size (2016-2027)
8.2 Asia-Pacific Psychiatric Medications Market Size by Type
8.2.1 Asia-Pacific Psychiatric Medications Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Psychiatric Medications Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Psychiatric Medications Market Size by Type (2016-2027)
8.3 Asia-Pacific Psychiatric Medications Market Size by Application
8.3.1 Asia-Pacific Psychiatric Medications Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Psychiatric Medications Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Psychiatric Medications Market Size by Application (2016-2027)
8.4 Asia-Pacific Psychiatric Medications Market Size by Region
8.4.1 Asia-Pacific Psychiatric Medications Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Psychiatric Medications Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Psychiatric Medications Market Size (2016-2027)
9.2 Latin America Psychiatric Medications Market Size by Type
9.2.1 Latin America Psychiatric Medications Market Size by Type (2016-2021)
9.2.2 Latin America Psychiatric Medications Market Size by Type (2022-2027)
9.2.3 Latin America Psychiatric Medications Market Size by Type (2016-2027)
9.3 Latin America Psychiatric Medications Market Size by Application
9.3.1 Latin America Psychiatric Medications Market Size by Application (2016-2021)
9.3.2 Latin America Psychiatric Medications Market Size by Application (2022-2027)
9.3.3 Latin America Psychiatric Medications Market Size by Application (2016-2027)
9.4 Latin America Psychiatric Medications Market Size by Country
9.4.1 Latin America Psychiatric Medications Market Size by Country (2016-2021)
9.4.2 Latin America Psychiatric Medications Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psychiatric Medications Market Size (2016-2027)
10.2 Middle East & Africa Psychiatric Medications Market Size by Type
10.2.1 Middle East & Africa Psychiatric Medications Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Psychiatric Medications Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Psychiatric Medications Market Size by Type (2016-2027)
10.3 Middle East & Africa Psychiatric Medications Market Size by Application
10.3.1 Middle East & Africa Psychiatric Medications Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Psychiatric Medications Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Psychiatric Medications Market Size by Application (2016-2027)
10.4 Middle East & Africa Psychiatric Medications Market Size by Country
10.4.1 Middle East & Africa Psychiatric Medications Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Psychiatric Medications Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Psychiatric Medications Introduction
11.1.4 Pfizer Revenue in Psychiatric Medications Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Psychiatric Medications Introduction
11.2.4 AstraZeneca Revenue in Psychiatric Medications Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Psychiatric Medications Introduction
11.3.4 Eli Lilly and Company Revenue in Psychiatric Medications Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Psychiatric Medications Introduction
11.4.4 GlaxoSmithKline Revenue in Psychiatric Medications Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Psychiatric Medications Introduction
11.5.4 Johnson & Johnson Revenue in Psychiatric Medications Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Psychiatric Medications Introduction
11.6.4 Novartis Revenue in Psychiatric Medications Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 H. Lundbeck
11.7.1 H. Lundbeck Company Details
11.7.2 H. Lundbeck Business Overview
11.7.3 H. Lundbeck Psychiatric Medications Introduction
11.7.4 H. Lundbeck Revenue in Psychiatric Medications Business (2016-2021)
11.7.5 H. Lundbeck Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Psychiatric Medications Introduction
11.8.4 Abbott Laboratories Revenue in Psychiatric Medications Business (2016-2021)
11.8.5 Abbott Laboratories Recent Development
11.9 Otsuka Pharmaceutical
11.9.1 Otsuka Pharmaceutical Company Details
11.9.2 Otsuka Pharmaceutical Business Overview
11.9.3 Otsuka Pharmaceutical Psychiatric Medications Introduction
11.9.4 Otsuka Pharmaceutical Revenue in Psychiatric Medications Business (2016-2021)
11.9.5 Otsuka Pharmaceutical Recent Development
11.10 Gedeon Richter
11.10.1 Gedeon Richter Company Details
11.10.2 Gedeon Richter Business Overview
11.10.3 Gedeon Richter Psychiatric Medications Introduction
11.10.4 Gedeon Richter Revenue in Psychiatric Medications Business (2016-2021)
11.10.5 Gedeon Richter Recent Development
11.11 Lupin Pharmaceuticals
11.11.1 Lupin Pharmaceuticals Company Details
11.11.2 Lupin Pharmaceuticals Business Overview
11.11.3 Lupin Pharmaceuticals Psychiatric Medications Introduction
11.11.4 Lupin Pharmaceuticals Revenue in Psychiatric Medications Business (2016-2021)
11.11.5 Lupin Pharmaceuticals Recent Development
11.12 Luye Pharma
11.12.1 Luye Pharma Company Details
11.12.2 Luye Pharma Business Overview
11.12.3 Luye Pharma Psychiatric Medications Introduction
11.12.4 Luye Pharma Revenue in Psychiatric Medications Business (2016-2021)
11.12.5 Luye Pharma Recent Development
11.13 SK Biopharmaceuticals
11.13.1 SK Biopharmaceuticals Company Details
11.13.2 SK Biopharmaceuticals Business Overview
11.13.3 SK Biopharmaceuticals Psychiatric Medications Introduction
11.13.4 SK Biopharmaceuticals Revenue in Psychiatric Medications Business (2016-2021)
11.13.5 SK Biopharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Psychiatric Medications Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antidepressants
Table 3. Key Players of Anti-anxiety Medications
Table 4. Key Players of Mood-stabilizing Medications
Table 5. Key Players of Antipsychotic Medications
Table 6. Global Psychiatric Medications Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Psychiatric Medications Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Psychiatric Medications Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Psychiatric Medications Market Share by Regions (2016-2021)
Table 10. Global Psychiatric Medications Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Psychiatric Medications Market Share by Regions (2022-2027)
Table 12. Psychiatric Medications Market Trends
Table 13. Psychiatric Medications Market Drivers
Table 14. Psychiatric Medications Market Challenges
Table 15. Psychiatric Medications Market Restraints
Table 16. Global Psychiatric Medications Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Psychiatric Medications Market Share by Players (2016-2021)
Table 18. Global Top Psychiatric Medications Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychiatric Medications as of 2020)
Table 19. Ranking of Global Top Psychiatric Medications Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Psychiatric Medications Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psychiatric Medications Product Solution and Service
Table 23. Date of Enter into Psychiatric Medications Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psychiatric Medications Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Psychiatric Medications Revenue Market Share by Type (2016-2021)
Table 27. Global Psychiatric Medications Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Psychiatric Medications Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Psychiatric Medications Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Psychiatric Medications Revenue Market Share by Application (2016-2021)
Table 31. Global Psychiatric Medications Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Psychiatric Medications Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Psychiatric Medications Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Psychiatric Medications Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Psychiatric Medications Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Psychiatric Medications Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Psychiatric Medications Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Psychiatric Medications Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Psychiatric Medications Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Psychiatric Medications Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Psychiatric Medications Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Psychiatric Medications Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Psychiatric Medications Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Psychiatric Medications Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Psychiatric Medications Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Psychiatric Medications Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Psychiatric Medications Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Psychiatric Medications Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Psychiatric Medications Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Psychiatric Medications Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Psychiatric Medications Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Psychiatric Medications Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Psychiatric Medications Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Psychiatric Medications Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Psychiatric Medications Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Psychiatric Medications Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Psychiatric Medications Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Psychiatric Medications Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Psychiatric Medications Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Psychiatric Medications Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Psychiatric Medications Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Psychiatric Medications Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Psychiatric Medications Product
Table 66. Pfizer Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. AstraZeneca Company Details
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Psychiatric Medications Product
Table 71. AstraZeneca Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Eli Lilly and Company Company Details
Table 74. Eli Lilly and Company Business Overview
Table 75. Eli Lilly and Company Psychiatric Medications Product
Table 76. Eli Lilly and Company Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 77. Eli Lilly and Company Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Psychiatric Medications Product
Table 81. GlaxoSmithKline Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Johnson & Johnson Company Details
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Psychiatric Medications Product
Table 86. Johnson & Johnson Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 87. Johnson & Johnson Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Psychiatric Medications Product
Table 91. Novartis Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. H. Lundbeck Company Details
Table 94. H. Lundbeck Business Overview
Table 95. H. Lundbeck Psychiatric Medications Product
Table 96. H. Lundbeck Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 97. H. Lundbeck Recent Development
Table 98. Abbott Laboratories Company Details
Table 99. Abbott Laboratories Business Overview
Table 100. Abbott Laboratories Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 101. Abbott Laboratories Recent Development
Table 102. Otsuka Pharmaceutical Company Details
Table 103. Otsuka Pharmaceutical Business Overview
Table 104. Otsuka Pharmaceutical Psychiatric Medications Product
Table 105. Otsuka Pharmaceutical Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 106. Otsuka Pharmaceutical Recent Development
Table 107. Gedeon Richter Company Details
Table 108. Gedeon Richter Business Overview
Table 109. Gedeon Richter Psychiatric Medications Product
Table 110. Gedeon Richter Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 111. Gedeon Richter Recent Development
Table 112. Lupin Pharmaceuticals Company Details
Table 113. Lupin Pharmaceuticals Business Overview
Table 114. Lupin Pharmaceuticals Psychiatric Medications Product
Table 115. Lupin Pharmaceuticals Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 116. Lupin Pharmaceuticals Recent Development
Table 117. Luye Pharma Company Details
Table 118. Luye Pharma Business Overview
Table 119. Luye Pharma Psychiatric Medications Product
Table 120. Luye Pharma Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 121. Luye Pharma Recent Development
Table 122. SK Biopharmaceuticals Company Details
Table 123. SK Biopharmaceuticals Business Overview
Table 124. SK Biopharmaceuticals Psychiatric Medications Product
Table 125. SK Biopharmaceuticals Revenue in Psychiatric Medications Business (2016-2021) & (US$ Million)
Table 126. SK Biopharmaceuticals Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psychiatric Medications Market Share by Type: 2020 VS 2027
Figure 2. Antidepressants Features
Figure 3. Anti-anxiety Medications Features
Figure 4. Mood-stabilizing Medications Features
Figure 5. Antipsychotic Medications Features
Figure 6. Global Psychiatric Medications Market Share by Application: 2020 VS 2027
Figure 7. Hospital Use Case Studies
Figure 8. Clinic Use Case Studies
Figure 9. Household Case Studies
Figure 10. Psychiatric Medications Report Years Considered
Figure 11. Global Psychiatric Medications Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Psychiatric Medications Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Psychiatric Medications Market Share by Regions: 2020 VS 2027
Figure 14. Global Psychiatric Medications Market Share by Regions (2022-2027)
Figure 15. Global Psychiatric Medications Market Share by Players in 2020
Figure 16. Global Top Psychiatric Medications Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychiatric Medications as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Psychiatric Medications Revenue in 2020
Figure 18. Global Psychiatric Medications Revenue Market Share by Type (2016-2021)
Figure 19. Global Psychiatric Medications Revenue Market Share by Type (2022-2027)
Figure 20. North America Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Psychiatric Medications Market Share by Type (2016-2027)
Figure 22. North America Psychiatric Medications Market Share by Application (2016-2027)
Figure 23. North America Psychiatric Medications Market Share by Country (2016-2027)
Figure 24. United States Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Psychiatric Medications Market Share by Type (2016-2027)
Figure 28. Europe Psychiatric Medications Market Share by Application (2016-2027)
Figure 29. Europe Psychiatric Medications Market Share by Country (2016-2027)
Figure 30. Germany Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Psychiatric Medications Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Psychiatric Medications Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Psychiatric Medications Market Share by Region (2016-2027)
Figure 40. China Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Psychiatric Medications Market Share by Type (2016-2027)
Figure 48. Latin America Psychiatric Medications Market Share by Application (2016-2027)
Figure 49. Latin America Psychiatric Medications Market Share by Country (2016-2027)
Figure 50. Mexico Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Psychiatric Medications Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Psychiatric Medications Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Psychiatric Medications Market Share by Country (2016-2027)
Figure 56. Turkey Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Psychiatric Medications Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 65. H. Lundbeck Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 66. Abbott Laboratories Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 67. Otsuka Pharmaceutical Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 68. Gedeon Richter Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 69. Lupin Pharmaceuticals Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 70. Luye Pharma Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 71. SK Biopharmaceuticals Revenue Growth Rate in Psychiatric Medications Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の臓器移植拒絶反応抑制剤市場規模・現状・予測（2021年-2027年） Organ transplant anti-rejection medications are drugs that prevent the body from attacking the transplanted organ cells after organ transplantation, and help organs survive in the recipient after organ transplantation. Market Analysis and Insights: Global Organ Transplant Anti-rejection Medications …- 世界の臓器移植拒絶反応抑制剤市場規模・現状・予測（2021年-2027年） Organ transplant anti-rejection medications are drugs that prevent the body from attacking the transplanted organ cells after organ transplantation, and help organs survive in the recipient after organ transplantation. Market Analysis and Insights: Global Organ Transplant Anti-rejection Medications …
- 世界の副鼻腔炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sinusitis Medications Market The global Sinusitis Medications market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界のADHD治療薬市場規模・現状・予測（2021年-2027年） ADHD medications can help reduce symptoms of hyperactivity, inattentiveness, and impulsivity in children and adults with attention deficit hyperactivity disorder (ADHD), formerly known as ADD. Market Analysis and Insights: Global ADHD Medications Market The global ADHD Medications market size is pr…
- 世界の変形性関節症治療薬市場規模・現状・予測（2021年-2027年） Osteoarthritis is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and l…